| Date Filed | Type | Description |
| 06/02/2023 |
4
| BISCHOFBERGER NORBERT W (Director) has filed a Form 4 on Morphic Holding, Inc.|
Txns:
| Granted 12,535 options to buy
@ $56.47, valued at
$707.9k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| BISCHOFBERGER NORBERT W (President & CEO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Bought 90,931 shares
@ $3.8329, valued at
$348.5k
Bought 206,198 shares
@ $3.7248, valued at
$768k
Bought 300,000 shares
@ $3.7817, valued at
$1.1M
|
|
| 04/29/2022 |
4/A
| BISCHOFBERGER NORBERT W (Director) has filed a Form 4 on Morphic Holding, Inc.|
Txns:
| Granted 9,888 options to buy
@ $64.79, valued at
$640.6k
|
|
| 02/17/2022 |
4
| BISCHOFBERGER NORBERT W (President & CEO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 400,000 options to buy
@ $7.3, valued at
$2.9M
|
|
| 02/17/2022 |
SC 13G/A
| BISCHOFBERGER NORBERT W reports a 10.5% stake in KRONOS BIO, INC. |
| 12/08/2021 |
4
| BISCHOFBERGER NORBERT W (President & CEO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Bought 14,356 shares
@ $12.085, valued at
$173.5k
|
|
| 06/17/2021 |
4
| BISCHOFBERGER NORBERT W (Director) has filed a Form 4 on Morphic Holding, Inc.|
Txns:
| Granted 12,000 options to buy
@ $64.79, valued at
$777.5k
|
|
| 05/04/2021 |
SC 13G
| BISCHOFBERGER NORBERT W reports a 10.6% stake in KRONOS BIO, INC. |
| 04/28/2021 |
3/A
| BISCHOFBERGER NORBERT W (President & CEO) has filed a Form 3/A on Kronos Bio, Inc. |
| 12/11/2020 |
4
| BISCHOFBERGER NORBERT W (President & CEO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 198,124 shares
@ $0
Granted 297,186 options to buy
@ $30.78, valued at
$9.1M
|
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2018 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 340 shares
@ $62.3475, valued at
$21.2k
Granted 16,468 shares
@ $0
Granted 6,805 shares
@ $0
Paid exercise price by delivering 7,071 shares
@ $80.69, valued at
$570.6k
Gifted 9,393 shares
@ $0
Gifted 9,393 shares
@ $0 |
|
| 02/05/2018 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 94,360 options to buy
@ $83.49, valued at
$7.9M
|
|
| 11/21/2017 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/26/2016 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Gifted 2,800 shares
@ $0 |
|
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/22/2013 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Gifted 1,097,810 shares
@ $0
Gifted 265,500 shares
@ $0
Gifted 265,500 shares
@ $0
Gifted 265,500 shares
@ $0
Gifted 265,333 shares
@ $0
Granted 1,097,810 shares
@ $0
Granted 265,500 shares
@ $0
Granted 265,500 shares
@ $0
Granted 265,500 shares
@ $0
Granted 265,333 shares
@ $0 |
|
| 10/16/2013 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 75,853 shares
@ $62.3938, valued at
$4.7M
Sold 14,147 shares
@ $63.2947, valued at
$895.4k
Exercised 90,000 options to buy
@ $14.5025, valued at
$1.3M
|
|
| 07/17/2013 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 90,000 shares
@ $57.3348, valued at
$5.2M
Exercised 90,000 options to buy
@ $14.5025, valued at
$1.3M
|
|
| 03/08/2013 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 24,000 shares
@ $0
Paid exercise price by delivering 12,523 shares
@ $45.4, valued at
$568.5k
|
|
| 07/03/2012 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 733 shares
@ $29.019, valued at
$21.3k
|
|
| 03/14/2012 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 19,800 shares
@ $0
Paid exercise price by delivering 8,767 shares
@ $46.16, valued at
$404.7k
|
|
| 01/30/2012 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 116,250 options to buy
@ $48.59, valued at
$5.6M
|
|
| 12/20/2011 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC |
| 04/06/2011 |
4/A
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 20,250 shares
@ $0
Paid exercise price by delivering 9,452 shares
@ $39.79, valued at
$376.1k
|
|
| 01/24/2011 |
4
| BISCHOFBERGER NORBERT W (EVP, R&D and CSO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 119,000 options to buy
@ $38.17, valued at
$4.5M
|
|
| 11/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|